Introduction. Abnormally invasive placenta involves abnormal adherence of the placenta to the myometrium and is associated with severe pregnancy complications such as blood transfusion and hysterectomy. Knowledge of outcomes has been limited by small sample sizes and a focus on maternal rather than neonatal outcomes. This study uses population-level data collected over 10 years to investigate maternal and neonatal outcomes and trends in incidence of abnormally invasive placenta (also known as placenta accreta, increta and percreta). Material and methods. A population-based record linkage study was performed, including all women who gave birth in New South Wales, Australia, between 2003 and 2012. Data were obtained from birth records, hospital admissions and deaths registrations. Modified Poisson regression models, adjusted for confounding factors, were used to quantify the effect of abnormally invasive placenta on adverse maternal and neonatal outcomes. Results. Abnormally invasive placenta was significantly associated with morbidity for mothers (adjusted relative risk 17.6, 99% confidence interval 14.5-21.2) and infants (adjusted relative risk 3.1, 99% confidence interval 2.7-3.5). Abnormally invasive placenta increased risk of stillbirth (relative risk 5.4, 99% confidence interval 4.0-7.3) and neonatal death (relative risk 8.0, 99% confidence interval 1.5-41.6). The overall rate of abnormally invasive placenta was 24.8 per 10 000 deliveries, and 22.7 per 10 000 among primiparae. Incidence increased by 30%, from 20.6 to 26.9 per 10 000, over the 10-year study period. Conclusions. Abnormally invasive placenta substantially increases the risk of severe adverse outcomes for mothers and babies, and the incidence is increasing. Delivery should occur in tertiary hospitals equipped with neonatal intensive care units. Clinicians should be cognizant of the risks, particularly to infants, and maintain a high index of suspicion of abnormally invasive placenta, including in primiparae.
Introduction
Abnormally invasive placenta (AIP) involves a group of pregnancy complications characterized in the mildest form by invasion of the placental villi into the decidual surface of the myometrium (placenta accreta). Two more severe variants exist, involving deep invasion into the myometrium (placenta increta), or complete penetration of the uterine serosa and potential invasion of surrounding organs, including the bladder or bowel (placenta percreta).
Incidence estimates of AIP vary widely, ranging from 1.7 to 90 per 10 000 (1, 2) . This wide range is likely due to differences in diagnosis and case definition (histopathological or clinical) of AIP, and being predominantly based on tertiary hospital-based studies (1) (2) (3) (4) . Incidence is thought to be increasing and associated with the increasing cesarean section rate (5, 6) .
Abnormally invasive placenta is associated with severe pregnancy complications such as postpartum hemorrhage and requires complex multidisciplinary management which may include large-volume blood transfusion, embolization of major arteries, hysterectomy, and admission to intensive care (7) . Previous studies have focused on maternal morbidity, and there has been limited exploration of neonatal outcomes. Additionally, previous studies have had small sample sizes and limited generalizability as a result of being case reports or institution-based medical reviews (1) (2) (3) . Studies using whole population data are rare, and are necessary for informing policy and practice, and counseling women about the risk of adverse outcomes for themselves and their babies. Therefore, this study aims to examine the outcomes following AIP among mothers and babies using populationlevel, routinely collected data over a 10-year period. We further sought to determine whether the incidence of AIP is increasing, and to describe the hospital settings in which women with AIP delivered. The data were linked by the NSW Center for Health Record Linkage using probabilistic methods based on personal identifiers, and unique project identifiers were assigned to each mother and baby, allowing for longitudinal linkage of deliveries and hospitalizations during and following pregnancy. Rates of missed and incorrect links are less than five per 1000 (8, 9) .
Material and methods
Women with AIP were identified by the presence of the ICD-10-AM diagnosis code O43.2 in the birth admission, which includes placenta accreta, increta, and percreta. Validation studies have shown generally high sensitivity and specificity for pregnancy complications reported in these data (10) , but the specific diagnosis code for AIP has not been validated. Therefore, deliveries with an AIP diagnosis were investigated for evidence of complications or procedures associated with the condition to demonstrate face validity. For mothers' outcomes, multiple births (for example twins) were counted as a single delivery. For infant outcomes, all infants of singleton and multifetal births were included. Counts of less than five were reported as "<5" in accordance with privacy restrictions.
The main outcomes were composite measures of severe maternal and neonatal morbidity. In the multivariable analysis, maternal morbidity was defined by the maternal morbidity outcome indicator (MMOI) prior to hospital discharge. The MMOI is a validated composite indicator of severe adverse outcomes, which encompasses an extensive list of diagnoses and procedures that indicate morbidity (11) . Blood transfusion was reported separately and therefore excluded from the morbidity indicator.
Key Message
Abnormally invasive placenta increases risk of severe maternal and neonatal morbidity, stillbirth, and neonatal death. Outcomes of interest for mothers also included obstetric hemorrhage, embolization in the birth admission, hysterectomy within six months, manual removal of placenta within six weeks, readmission within six weeks, and ICU admission. In the multivariable analysis, neonatal morbidity was defined by a composite of the neonatal adverse outcomes indicator (NAOI) (12) , stillbirth, or infant death during the birth hospitalization. Deaths were excluded from the NAOI in univariate analysis and reported separately. Other neonatal outcomes included gestational age, small-for-gestational-age, Apgar score at five minutes, resuscitation, and admission to neonatal intensive care unit (NICU) or special care nursery, stillbirth, neonatal death and death prior to discharge. Length of stay was calculated as the difference between the day of discharge and the day of admission for mothers, and the day of discharge and date of birth for infants, with stays of less than 24 h rounded up to one day.
Tertiary hospitals were defined as tertiary public hospitals with a NICU (annual birth volume ≥1000). Private hospitals were grouped together (annual birth volume ≥20), with non-tertiary public hospitals grouped by annual average number of births (large: ≥1000, medium: 500-999, small: 1-499) (13) . To determine the level of access to blood products, hospitals were grouped according to whether they had a 24-h on-site blood bank, onsite cross-matching facilities during the day but on-call after hours, or no cross-matching facilities (14) .
Trends over time were tested using the Cochran-Armitage test for binomial outcomes and the JonckheereTerpstra test for multinomial outcomes (15, 16) .
For the adjusted analyses, potential confounders considered were maternal age, socioeconomic disadvantage (based on maternal postcode), whether the mother was born in Australia, hypertension, diabetes, prior cesarean section (mothers' outcomes only), baby's birth year (infants' outcomes only), and whether the mother smoked during pregnancy. Parity was excluded due to strong collinearity with prior cesarean section and maternal age. Only true confounders, i.e. factors likely to be correlated with both AIP and morbidity or mortality, were considered as covariates, consistent with etiological modeling. Placenta previa, gestational age and small-forgestational-age were not included as covariates because of the strong likelihood that they lie on the causal pathway from AIP to morbidity. Multivariable analyses were restricted to singleton deliveries given the different risk profile of multiple pregnancies.
To test the association between adverse outcomes and AIP, modified Poisson regression models with robust error variances were used, taking into account clustering within individual mothers (all models, to allow for repeat pregnancies) and deliveries (where multiple pregnancies were included). Potential confounders were included in the full multivariable model where p < 0.2 in univariate analysis. Backwards selection was used to remove factors not significant at the 1% level from the final model (17) . Statistical analyses were performed using SAS ENTER-PRISE GUIDE v6.1 (SAS Institute Inc., Cary, NC, USA). Results are presented as relative risks (RR) with 99% confidence intervals (CI). Adjusted and crude analyses were repeated with stratification by gestational age (term and preterm). Ethics approval for this study was granted by the NSW Population and Health Services Research Ethics Committee (2006/06/011).
Results
There were 922 925 deliveries of infants of at least 20 weeks' gestation during the period 2003 to 2012. This represents 595 597 mothers, 937 143 infants and 1 381 398 linked hospital and birth records for the perinatal period. There were 2285 deliveries that involved an abnormally invasive placenta diagnosis, involving a total of 2248 mothers.
Of the 2285 cases of AIP, 2229 (97.5%) had a record of known associated diagnoses or procedures used for management, including cesarean delivery, hysterectomy within six months of giving birth, or any of the following in the birth admission: obstetric hemorrhage, manual removal of placenta, or arterial embolization.
The overall rate of AIP throughout the study period was 24.8 per 10 000. The annual rate of AIP increased by 30.6% over the study period, from 20.6 per 10 000 to 26.9 per 10 000 (p = 0.009; Figure 1 ). For primiparous mothers the rate was 22.7 per 10 000, with a non-significant increase from 20. Characteristics of deliveries with and without AIP are shown in Table 1 . Mothers with AIP were older, had higher parity and greater socioeconomic advantages (Table 1) . A higher proportion of mothers with AIP had placenta previa, a history of cesarean section, assisted reproductive technology in the year prior to birth, hypertension, and female infants compared to those without (Table 1) . Almost 40% of mothers with AIP had a cesarean delivery, compared with 29% for mothers without AIP (Table 1) . There were 70 multiple births to women with AIP (3.1%) compared with 13 887 (1.5%) for women without AIP. The median length of stay for the birth admission for mothers with AIP was five days [interquartile range (IQR) [4] [5] [6] [7] , compared with four (IQR 2-5) for those without. The median length of stay in the birth admission for infants born to a mother with AIP was four days (IQR 3-6) and three (IQR 2-5) for those without.
Adverse outcomes of deliveries with and without AIP are shown in Table 2 . Abnormally invasive placenta was associated with poor maternal outcomes, including maternal morbidity, hemorrhage, maternal ICU admission and readmission. In all, 280 mothers with AIP underwent a hysterectomy within six months (12.3%), compared with 460 mothers without (0.05%). Among primiparous mothers, 21 with AIP had a hysterectomy (2.4%), compared with 97 mothers (0.03%) without AIP. No mothers with AIP died during the postnatal period (without AIP: n = 48, <0.01%).
Almost 25% of infants born to mothers with AIP were born preterm, compared with 7.3% among mothers without AIP. Both preterm and term infants born following AIP were at increased risk of neonatal morbidity and resuscitation (Table 2) . Preterm infants were also at increased risk of low Apgars and death prior to discharge, while term infants were at increased risk of being smallfor-gestational-age or admitted to neonatal intensive care or special care nurseries. Rates of all adverse outcomes were higher in preterm than term babies. In all, 77 infants of mothers with AIP were stillborn (3.3%), compared with 5662 (0.6%) for mothers without (RR 5.4, 99% CI 4.0-7.3) although the difference in risk was not significant when stratified by prematurity (Table  2 ). Of the 35 stillbirths for whom time of death data were available, 18 (51.4%) were recorded as having occurred prior to onset of labor, six (17.1%) at some time prior to birth, and 11 (31.4%) during labor (without AIP: 66.7% before labor, 20.7% at some time prior to birth and 11.7% during labor). Among women with AIP, identified causes of stillbirth include preterm rupture of membranes (n = 7, 25.9%), congenital abnormality (n = 5, 18.5%), antepartum hemorrhage (n < 5, <10%), and infection (n < 5, <10%). Among women without AIP, there were 306 (13.8%) stillbirths with preterm rupture of membranes, 603 (27.2%) with congenital abnormalities, 251 (11.3%) with antepartum hemorrhage and 181 (8.2%) with infection. No stillbirths in the AIP group were explained by fetal growth restriction (without AIP: n = 138, 6.2% of explained stillbirths). The majority (92.2%) of stillbirths with AIP occurred at 32 weeks' gestation or earlier, compared with 64.9% without AIP; 5.2% occurred at 33-36 weeks (without AIP: 13.0%); and only 2.6% at 37 weeks or later (without AIP: 22.1%). There was a significantly higher overall risk of neonatal death associated with AIP (RR 8.0, 99% CI 1.5-41.6), although when stratified by prematurity the higher risk ratios were not statistically significant. Sixty percent (n = 43) of explained neonatal deaths were caused by extreme prematurity (compared with 42.6% without AIP), with the remainder by neurological, infectious, gastrointestinal or cardiorespiratory causes. Abnormally invasive placenta was associated with significantly higher maternal morbidity in the adjusted analysis [adjusted relative risk (aRR) 17.6, 99% CI 14.5-21.2; Table 3 ]. Abnormally invasive placenta also increased the risk of neonatal morbidity, stillbirth or death more than threefold (aRR 3.1, 99% CI 2.7-3.5; Table 3 ).
Mothers with AIP most commonly gave birth in tertiary hospitals, followed by private hospitals and large non-tertiary hospitals (Table 1) . One-fifth of women with AIP gave birth in a small to medium level hospital. The majority of mothers with AIP gave birth in a hospital with either 24-h onsite or on-call access to blood transfusion.
Although there was no significant change in overall trends in place of birth among women with AIP (p = 0.08), the proportion of all deliveries with AIP in tertiary hospitals increased from 30.3% in 2003 to 36.1% in 2012 (without AIP: 26.7 to 28.7%, p < 0.001).
Discussion
Abnormally invasive placenta was significantly associated with a range of adverse outcomes for both mothers and neonates, including a considerably increased risk of stillbirth (RR 5.4, 99% CI 4.0-7.3) and neonatal death (RR 8.0, 99% CI 1.5-41.6). Over the 10-year study period the incidence of AIP increased significantly, with an overall rate of 24.8 per 10 000. The rate of AIP among primiparae was almost as high as the overall rate at 22.7 per 10 000, indicating a need for clinicians to be cognizant of the risk of AIP in this group.
The overall rate of AIP in our study was 24.8 per 10 000, which is within the wide range of estimates reported in the literature of 1.7-90 per 10 000 (4,18-21). We found a 30% increase in the incidence of AIP over the 10-year study period, consistent with increases reported internationally (5, 22) . This is often suggested to be associated with the cesarean section rate (22) . The increased use of in vitro fertilization (IVF) may also be associated, supported by our finding that IVF rates were twice as high among women with AIP as among those without. Evidence for a link between IVF and AIP in the literature is limited by low numbers (1) and lack of adjustment for confounding factors (particularly maternal age) (23, 24) . We found strong evidence of an association between AIP and perinatal death in addition to the known maternal morbidity. The overall risk of stillbirth increased more than fivefold in women with AIP compared to those without, with the majority occurring among preterm infants. Causes of stillbirth included preterm rupture of membranes, congenital abnormalities, antepartum hemorrhage and infection. Over 90% occurred at or below 32 weeks' gestation. Interestingly, growth restriction was not a cause of stillbirth in our cohort of babies, although our study found an increased risk of small-for-gestational-age in term infants (RR 1.4, 99% CI 1.1-1.6), also reported elsewhere (2). Previous smaller studies have found significantly higher rates of stillbirth (4) and perinatal death (stillbirth and death within seven days of birth) (21, 25) . However, causes and gestational ages of perinatal death were not available for those studies.
Furthermore, we found substantially higher rates of neonatal death in the setting of AIP, with almost all of the deaths among preterm infants. Infants of mothers with AIP had significantly increased risk of the neonatal adverse outcome indicator (preterm infants: RR 1.4, 99% CI 1.2-1.5; term infants: RR 1.7, 99% CI 1.2-2.2). While others have noted increased risk of neonatal morbidity among preterm births, we also saw increased risk among term births, thus premature delivery was not the only cause of morbidity for neonates whose mother had AIP (21, 25) . After adjustment for other pregnancy factors, the overall relative risk for neonatal morbidity, stillbirth or death prior to discharge persisted (aRR 3.1, 99% CI 2.7-3.5). Infants identified by this indicator have a 10 times higher risk of death and are more likely to be readmitted in the first year of life (12) . A number of previous studies that did not find significant differences in neonatal outcomes were limited by small sample sizes (3, 26) . We found that AIP was also associated with less specific markers of neonatal morbidity including low Apgar scores at five minutes (25) , resuscitation, admission to NICU or special care nursery, and small-for-gestational-age (2).
Mothers with AIP were found to have an 18-fold greater risk of maternal morbidity, after adjusting for other pregnancy characteristics. Higher risk of hemorrhage, blood transfusion, readmission and ICU admission were found, consistent with previous studies (4, (19) (20) (21) (26) (27) (28) . Hysterectomy was recorded for 12% of women with AIP, lower than reported elsewhere (4, 7, 21) ; however, there is known under-reporting of hysterectomy in these datasets and the true hysterectomy rate is likely to be higher (11) . Differences in case definition between studies, local practice and management guidelines, and the institution-based tertiary-care settings of many previous studies may also play a role.
Suspicion is often reserved for multiparous women, but we found primiparous women are susceptible to AIP, occurring at close to the overall rate and constituting 38% of all cases. Previous studies have provided varied estimates of primiparity among women with AIP, generally between 9 and 29% (1, 6, 24) , although one study of 28 women reported 54% primiparity (29) . Our finding highlights the need for clinicians to be cognizant of the risk among primiparae. Characteristics of women with AIP were consistent with previous studies, being older (1, 3, 5, 24) , with higher rates of placenta previa (1, 3, 5, 29) , prior cesarean section (3, 6, 24) , hypertension (26) , female fetal sex (30) , multiple birth (1), uterine anomaly (31), higher parity (1) and socioeconomic status than women without AIP (1) .
Given the strong association we found between AIP and major adverse outcomes for mothers and neonates, it is important that women with suspected AIP are referred for delivery in tertiary hospitals equipped with NICU. The increased risk of stillbirth, early preterm birth and smallfor-gestational-age highlight the need for close monitoring of fetal growth where AIP is suspected. Only around onethird of mothers with AIP gave birth in tertiary centers, although this increased (albeit nonsignificantly) over the study period. As over 20% of women with AIP delivered in small to medium hospitals, there is a need for clinicians to be aware of and trained to manage the associated risks, including the possible need to transport the sick neonate to larger centers for specialized care.
The increased risk of obstetric hemorrhage and transfusion for mothers with AIP emphasizes the need for blood bank access during delivery. Reassuringly, our study found that the majority of births (over 97%) for women with AIP occurred in hospitals with access to blood products, with almost two-thirds available 24 h onsite. These rates are higher than among women without AIP, suggesting that many of these pregnancies are identified as high-risk. Hospitals without cross-matching capability should have contingencies in place for accessing blood products.
A major strength of this study is the use of routinely collected population-level data and the clinical diagnosis code introduced to the ICD-10-AM in 2002. This provided 10 years' complete population data on AIP. The resulting large cohort of women and babies with AIP (more than four times the size of previously published cohorts) (6, 7, 24, 25) allowed in-depth examination of rare outcomes such as stillbirth and neonatal death, and appropriate adjustment for confounding factors.
Our data are limited by an inability to distinguish AIP from the more severe variants of increta and percreta.
However, previous studies suggest that placenta accreta represents the majority of cases (75-80%) (3, 32) . Although the ICD-10-AM diagnosis code has not been validated, face validity is demonstrated by the finding that most women with AIP had a record of manual removal of placenta, hysterectomy and embolization, hemorrhage or cesarean. Our reliance on clinical diagnosis may have allowed us to capture the clinical spectrum of disease, in contrast to histological diagnosis, which some studies have reported leads to under-reporting of the clinical/surgical diagnosis of AIP (33) . Information on hospital access to blood products was based on an audit conducted early in the study period and may not reflect availability at the end of the study period.
Our findings demonstrate that AIP increases the risk of severe adverse outcomes for both mothers and babies. The severity of outcomes, combined with the increase in incidence, highlights the need for clinicians to be cognizant of the risks, particularly to infants. Physicians should maintain an index of suspicion of AIP, even among primiparae.
